Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: Underlying mechanisms
暂无分享,去创建一个
[1] J. Licinio,et al. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[2] Yasuyoshi Watanabe,et al. Pyrogenic cytokines injected into the rat cerebral ventricle induce cyclooxygenase‐2 in brain endothelial cells and also upregulate their receptors , 2001, The European journal of neuroscience.
[3] K. Becker,et al. Sensitization and tolerization to brain antigens in stroke , 2009, Neuroscience.
[4] S. Akira,et al. Toll-like receptors in innate immunity. , 2004, International immunology.
[5] Andrew H. Miller,et al. Cytokines and psychopathology: lessons from interferon-alpha. , 2004, Biological psychiatry.
[6] William A Banks,et al. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. , 2005, Current pharmaceutical design.
[7] H. Anisman,et al. Influence of poly I:C on sickness behaviors, plasma cytokines, corticosterone and central monoamine activity: Moderation by social stressors , 2007, Brain, Behavior, and Immunity.
[8] B. Grubeck‐Loebenstein,et al. Age-related changes in immunity: implications for vaccination in the elderly , 2007, Expert Reviews in Molecular Medicine.
[9] R. Adams,et al. Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS Investigators. , 1998, Stroke.
[10] O. Steward,et al. Genetic influences on cellular reactions to spinal cord injury: Activation of macrophages/microglia and astrocytes is delayed in mice carrying a mutation (WldS) that causes delayed Wallerian degeneration , 1996, The Journal of comparative neurology.
[11] J. Borrell,et al. Interleukin-1 affects the behavioral despair response in rats by an indirect mechanism which requires endogenous CRF , 1990, Brain Research.
[12] S. Dudek,et al. Arachidonic acid cascade in endothelial pathobiology. , 2005, Microvascular research.
[13] C. Cunningham,et al. Atypical inflammation in the central nervous system in prion disease , 2002, Current opinion in neurology.
[14] V. Perry,et al. Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve , 1994, Journal of neurocytology.
[15] R. Hintzen,et al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. , 2006, Brain : a journal of neurology.
[16] V. Perry,et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS , 2002, Glia.
[17] F. Dudek,et al. Cell-Specific Expression of Connexins and Evidence of Restricted Gap Junctional Coupling between Glial Cells and between Neurons , 2001, The Journal of Neuroscience.
[18] E. J. Green,et al. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury , 2005, The Journal of experimental medicine.
[19] A. Świergiel,et al. Distinct Roles for Cyclooxygenases 1 and 2 in Interleukin-1-Induced Behavioral Changes , 2002, Journal of Pharmacology and Experimental Therapeutics.
[20] R. Dantzer,et al. Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice. , 1994, Brain research. Molecular brain research.
[21] C HISCOCK,et al. YELLOW NAILS AND LYMPHOEDEMA. , 1964, Lancet.
[22] Y. Nasuhara,et al. Ligand‐induced differentiation of glucocorticoid receptor (GR) trans‐repression and transactivation: preferential targetting of NF‐κB and lack of I‐κB involvement , 1999, Biochemical Society transactions.
[23] Jie Zhao,et al. Lipopolysaccharide-activated SHP-1-deficient motheaten microglia release increased nitric oxide, TNF-alpha, and IL-1beta. , 2006, Glia.
[24] T. Lundeberg,et al. Activation of Vagal Afferents after Intravenous Injection of Interleukin-1β: Role of Endogenous Prostaglandins , 1998, The Journal of Neuroscience.
[25] Neuropathological stageing of Alzheimer related changes correlates with psychometrically assessed intellectual status H. Braak, C. Duyckaerts, E. Braak and F. Piette. Depts of Anatomy and Neuropathology, Goethe University and Hopital de la Salpetriere, Frankfurt, Germany and Paris, France , 1992, Neurobiology of Aging.
[26] V. Perry,et al. TGFβ1 regulates the inflammatory response during chronic neurodegeneration , 2006, Neurobiology of Disease.
[27] C. Saper,et al. Intravenous lipopolysaccharide induces cyclooxygenase 2‐like immunoreactivity in rat brain perivascular microglia and meningeal macrophages , 1997, The Journal of comparative neurology.
[28] R. Dantzer,et al. Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice. , 2000, The European journal of neuroscience.
[29] T. Kondo,et al. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue , 2003, Neuroscience.
[30] T. Bártfai,et al. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. , 1993, Brain research.
[31] S. Feldman,et al. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double‐blind placebo‐controlled trial , 2005, The British journal of dermatology.
[32] R. Kuljiš,et al. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. , 1993, Journal of neuroimmunology.
[33] E. Tobinick. Perispinal etanercept for treatment of Alzheimer's disease. , 2007, Current Alzheimer research.
[34] M. Herkenham,et al. Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat , 1999, Journal of Neuroimmunology.
[35] W. Millikan,et al. Muromonab CD‐3: A Review of Its Pharmacology, Pharmacokinetics, and Clinical Use in Transplantation , 1991, Pharmacotherapy.
[36] Petra Harris,et al. Selective effects of upper respiratory tract infection on cognition, mood and emotion processing: A prospective study , 2008, Brain, Behavior, and Immunity.
[37] V. Pavlov,et al. Controlling inflammation: the cholinergic anti-inflammatory pathway. , 2006, Biochemical Society transactions.
[38] M. Kluger,et al. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. , 1997, The American journal of physiology.
[39] L. Blumhardt,et al. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis , 1998, Journal of neurology, neurosurgery, and psychiatry.
[40] C. Brayne,et al. Risk factors for incident dementia in England and Wales: The Medical Research Council Cognitive Function and Ageing Study. A population-based nested case-control study. , 2006, Age and ageing.
[41] S. Akira,et al. Microbial recognition by Toll-like receptors. , 2004, Journal of dermatological science.
[42] T. Pollmächer,et al. Endotoxin-induced changes in human working and declarative memory associate with cleavage of plasma “readthrough” acetylcholinesterase , 2007, Journal of Molecular Neuroscience.
[43] Jie Zhao,et al. Loss of SHP-1 phosphatase alters cytokine expression in the mouse hindbrain following cochlear ablation. , 2004, Cytokine.
[44] John Savill,et al. A blast from the past: clearance of apoptotic cells regulates immune responses , 2002, Nature Reviews Immunology.
[45] A. A. Romanovsky,et al. Cellular and Molecular Bases of the Initiation of Fever , 2006, PLoS biology.
[46] C. Saper,et al. Regional induction of tumor necrosis factor alpha expression in the mouse brain after systemic lipopolysaccharide administration. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[47] U. Dirnagl,et al. Stroke-induced immunodepression and post-stroke infections: Lessons from the preventive antibacterial therapy in stroke trial , 2009, Neuroscience.
[48] K. Nakao,et al. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[49] V. Perry,et al. Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines , 2007, Brain, Behavior, and Immunity.
[50] R. Kohman,et al. Age increases vulnerability to bacterial endotoxin-induced behavioral decrements , 2007, Physiology & Behavior.
[51] J. W. Rudy,et al. Peripheral infection and aging interact to impair hippocampal memory consolidation , 2006, Neurobiology of Aging.
[52] A. Świergiel,et al. The Role of Cyclooxygenases in Endotoxin- and Interleukin-1-Induced Hypophagia , 2000, Brain, Behavior, and Immunity.
[53] R. Dantzer,et al. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins , 1991, Brain Research.
[54] T. Hamazaki,et al. Differential effects of selective cyclooxygenase (COX)-1 and COX-2 inhibitors on anorexic response and prostaglandin generation in various tissues induced by zymosan. , 2006, Biological & pharmaceutical bulletin.
[55] C. Dinarello,et al. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. , 1986, Science.
[56] N. Rothwell,et al. Circulating interleukin‐6 mediates the febrile response to localised inflammation in rats , 2000, The Journal of physiology.
[57] L. Piccio,et al. Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.
[58] F. Aloisi. Immune function of microglia , 2001, Glia.
[59] A. Świergiel,et al. Endotoxin- and Interleukin-1–Induced Hypophagia Are Not Affected by Adrenergic, Dopaminergic, Histaminergic, or Muscarinic Antagonists , 1999, Pharmacology Biochemistry and Behavior.
[60] Jing Chen,et al. Interleukin-6 Facilitates Lipopolysaccharide-Induced Disruption in Working Memory and Expression of Other Proinflammatory Cytokines in Hippocampal Neuronal Cell Layers , 2006, The Journal of Neuroscience.
[61] T. Strandberg,et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.
[62] B. Pedersen,et al. Low-dose endotoxemia and human neuropsychological functions , 2005, Brain, Behavior, and Immunity.
[63] V. Perry,et al. Axon pathology in neurological disease: a neglected therapeutic target , 2002, Trends in Neurosciences.
[64] M. Ono,et al. Modulation of Immune Complex–induced Inflammation In Vivo by the Coordinate Expression of Activation and Inhibitory Fc Receptors , 1999, The Journal of experimental medicine.
[65] H. Besedovsky,et al. Physiology of psychoneuroimmunology: A personal view , 2007, Brain, Behavior, and Immunity.
[66] Colm Cunningham,et al. Systemic infections and inflammation affect chronic neurodegeneration , 2007, Nature Reviews Immunology.
[67] Sofia Agelaki,et al. Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in Mice , 2002, Infection and Immunity.
[68] A. Arimura,et al. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. , 1989, The American journal of physiology.
[69] C. Holmes,et al. Association between Dementia and Infectious Disease: Evidence from a Case-Control Study , 2005, Alzheimer disease and associated disorders.
[70] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[71] E. Reinke,et al. Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides. , 2006, Immunology letters.
[72] C. Lucchinetti,et al. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. , 2001, Trends in molecular medicine.
[73] V. Perry,et al. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease , 2002, Neuroscience.
[74] J. Rogers,et al. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. , 2006, Journal of Alzheimer's disease : JAD.
[75] Jie Zhao,et al. Lipopolysaccharide‐activated SHP‐1‐deficient motheaten microglia release increased nitric oxide, TNF‐α, and IL‐1β , 2006 .
[76] R. Dantzer,et al. Mechanisms of the Behavioral Effects of Interleukin 1 Role of Prostaglandins and CRF a , 1992, Annals of the New York Academy of Sciences.
[77] H. Nakanishi,et al. Involvement of COX-1 and up-regulated prostaglandin E synthases in phosphatidylserine liposome-induced prostaglandin E2 production by microglia , 2006, Journal of Neuroimmunology.
[78] A. Blomqvist,et al. IL-1beta and LPS induce anorexia by distinct mechanisms differentially dependent on microsomal prostaglandin E synthase-1. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[79] A. Świergiel,et al. Influenza Virus Infection of Mice Induces Anorexia: Comparison with Endotoxin and Interleukin-1 and the Effects of Indomethacin , 1997, Pharmacology Biochemistry and Behavior.
[80] P. Mcgeer,et al. Alzheimer disease and neuroinflammation. , 2000, Journal of neural transmission. Supplementum.
[81] A. Mildner,et al. Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice , 2006, Nature Immunology.
[82] Shizuo Akira,et al. TLR signaling pathways. , 2004, Seminars in immunology.
[83] E. Sternberg,et al. Neural‐Immune Interactions in Health and Disease , 2002, The Journal of clinical investigation.
[84] F. Pitossi,et al. Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice , 1997, Journal of neuroscience research.
[85] M. Esiri,et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.
[86] B. Blom,et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.
[87] L. Piccio,et al. Blockade of TREM‐2 exacerbates experimental autoimmune encephalomyelitis , 2007, European journal of immunology.
[88] C. Saper,et al. Specific roles of cyclooxygenase‐1 and cyclooxygenase‐2 in lipopolysaccharide‐induced fever and fos expression in rat brain , 2003, The Journal of comparative neurology.
[89] M. Jeffrey,et al. Pathology and pathogenesis of bovine spongiform encephalopathy and scrapie. , 2004, Current topics in microbiology and immunology.
[90] S. Gordon,et al. Alternative activation of macrophages: mechanism and functions. , 2010, Immunity.
[91] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[92] M. Brouns,et al. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? , 1992, Brain Research.
[93] Stephen Kent,et al. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[94] R. Gaykema,et al. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: Possible anatomical substrates for viscerosensory modulation of exploratory behavior , 2008, Brain, Behavior, and Immunity.
[95] L. Benowitz,et al. The role of macrophages in optic nerve regeneration , 2009, Neuroscience.
[96] Colm Cunningham,et al. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C) , 2007, Brain, Behavior, and Immunity.
[97] Y. Nomura,et al. STAT3 activation and c-FOS expression in the brain following peripheral administration of bacterial DNA , 2005, Journal of Neuroimmunology.
[98] J. Vane,et al. Prostaglandins and thromboxanes from fatty acids. , 1986, Progress in lipid research.
[99] R. Dantzer,et al. Role of interleukin‐1β and tumour necrosis factor‐α in lipopolysaccharide‐induced sickness behaviour: a study with interleukin‐1 type I receptor‐deficient mice , 2000 .
[100] A. Dunn,et al. Effects of interleukin-1β and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests , 2007, Pharmacology Biochemistry and Behavior.
[101] W. Hop,et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. , 2002, Brain : a journal of neurology.
[102] V. Perry,et al. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease , 2003, The European journal of neuroscience.
[103] Caroline E. Wright,et al. Acute inflammation and negative mood: Mediation by cytokine activation , 2005, Brain, Behavior, and Immunity.
[104] S. Rivest,et al. Anti‐inflammatory effects of prostaglandin E2 in the central nervous system in response to brain injury and circulating lipopolysaccharide , 2001, Journal of neurochemistry.
[105] H. Neumann,et al. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[106] R. Ransohoff. Microgliosis: the questions shape the answers , 2007, Nature Neuroscience.
[107] C. Farina,et al. Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.
[108] C. J. Crosby,et al. The Fate of Axonal Debris in Wallerian Degeneration of Rat Optic and Sciatic Nerves: Electron Microscopy and Immunofluorescence Studies with Neurofilament Antisera , 1981, Journal of neuropathology and experimental neurology.
[109] J. Glowinski,et al. Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes , 1995, Nature.
[110] R. Dantzer,et al. Molecular Basis of Sickness Behavior a , 1998, Annals of the New York Academy of Sciences.
[111] R. Kuljiš,et al. Identification of FcγRI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease , 1993, Journal of Neuroimmunology.
[112] P. Gasque,et al. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. , 2003, Molecular immunology.
[113] Jing Chen,et al. Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system , 2005 .
[114] T. Pollmächer,et al. Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.
[115] R. Ravid,et al. Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators , 2006, Glia.
[116] R. Dantzer,et al. Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice , 2000, Physiology & Behavior.
[117] R. Dantzer,et al. Mechanisms of the behavioural effects of cytokines. , 1999, Advances in experimental medicine and biology.
[118] R. Dantzer,et al. Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.
[119] H Bratzke,et al. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. , 1998, Progress in brain research.
[120] Y. Nasuhara,et al. Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. , 1996, British journal of pharmacology.
[121] D. Franchimont. Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies , 2004, Annals of the New York Academy of Sciences.
[122] H. Lassmann,et al. Inflammation in the nervous system: The human perspective , 2001, Glia.
[123] V. Perry,et al. Axonal damage in acute multiple sclerosis lesions. , 1997, Brain : a journal of neurology.
[124] J. Julien,et al. Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease , 2006, Neuron.
[125] V. Perry,et al. Central and Systemic Endotoxin Challenges Exacerbate the Local Inflammatory Response and Increase Neuronal Death during Chronic Neurodegeneration , 2005, The Journal of Neuroscience.
[126] T. Hyphantis,et al. Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.
[127] B. Beutler,et al. How we detect microbes and respond to them: the Toll‐like receptors and their transducers , 2003, Journal of leukocyte biology.
[128] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[129] E. Benarroch,et al. Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system. , 2005, Mayo Clinic proceedings.
[130] R. Bronson,et al. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. , 2007, The American journal of pathology.
[131] A. Dunn. Effects of cytokines and infections on brain neurochemistry , 2006, Clinical Neuroscience Research.
[132] B. Hart. Biological basis of the behavior of sick animals , 1988, Neuroscience & Biobehavioral Reviews.
[133] V. Perry,et al. Systemic inflammation switches the inflammatory cytokine profile in CNS Wallerian degeneration , 2008, Neurobiology of Disease.
[134] W. Hop,et al. Self reported stressful life events and exacerbations in multiple sclerosis:prospective study , 2003, BMJ : British Medical Journal.
[135] L. Lanier,et al. Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP121 , 2006, The Journal of Immunology.
[136] G. Kreutzberg. Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.
[137] W. Sibley,et al. CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS , 1985, The Lancet.
[138] Anders Blomqvist,et al. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis , 2003, Nature Neuroscience.
[139] R. Dantzer,et al. Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? , 2000, Autonomic Neuroscience.
[140] C. Blatteis,et al. The onset of fever: new insights into its mechanism. , 2007, Progress in brain research.
[141] H. Yano,et al. The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice , 2008, Physiology & Behavior.
[142] L. Minghetti,et al. Cyclooxygenase‐2 is highly expressed in microglial‐like cells in a murine model of prion disease , 2000, Glia.
[143] T. Bergström,et al. Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study , 1993, Journal of Neurology.
[144] Andrew H. Miller,et al. Cytokines and psychopathology: Lessons from interferon-α , 2004, Biological Psychiatry.
[145] V. Perry,et al. Systemic infection, interleukin 1β, and cognitive decline in Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.
[146] M. Nilsson,et al. Astrocyte activation and reactive gliosis , 2005, Glia.
[147] S. Rivest,et al. Unraveling the Molecular Details Involved in the Intimate Link between the Immune and Neuroendocrine Systems , 2004, Experimental biology and medicine.
[148] C. Plata-salamán. Dexamethasone inhibits food intake suppression induced by low doses of interleukin-1 β administered intracerebroventricularly , 1991, Brain Research Bulletin.
[149] S. Narumiya,et al. Prostaglandin E receptor EP1 controls impulsive behavior under stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[150] R. Dantzer,et al. Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .
[151] M. I. Norlinah,et al. The predictors of early infection after an acute ischaemic stroke. , 2003, Singapore medical journal.
[152] A. Świergiel,et al. CRF-Deficient Mice Respond Like Wild-Type Mice to Hypophagic Stimuli , 1999, Pharmacology Biochemistry and Behavior.